The number of people with susceptibility test result for rifampicin in Syrian Arab Republic
Syrian Arab Republic: The number of people with susceptibility test result for rifampicin was 705 in 2021. ▲ Rising
Latest (2021)
705
Change on year
down 22.7%
World rank
71st
of 155 countries
All-time high
912
in 2020
All-time low
201
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Syrian Arab Republic, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Syrian Arab Republic stood at 705.
The figure is down 22.7% on the previous year and up 250.7% over five years.
That places Syrian Arab Republic 71st out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Syrian Arab Republic, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 201 | — |
| 2018 | 367 | +82.6% |
| 2019 | 906 | +146.9% |
| 2020 | 912 | +0.7% |
| 2021 | 705 | -22.7% |
Syrian Arab Republic compared with similar countries
- Syrian Arab Republic's 705 is below the median for low income countries, which is 1,934, 36% of the median. (15 countries reporting)
- Syrian Arab Republic's 705 is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 406, 1.7× the median. (16 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 491.33 | 201 | 906 | 3 |
| 2020s | 808.5 | 705 | 912 | 2 |
Countries ranked near Syrian Arab Republic
More health data for Syrian Arab Republic
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Syrian Arab Republic?
- The number of people with susceptibility test result for rifampicin in Syrian Arab Republic was 705 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Syrian Arab Republic?
- The highest recorded value was 912 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Syrian Arab Republic?
- The lowest recorded value was 201 in 2017.
- How does Syrian Arab Republic rank for the number of people with susceptibility test result for rifampicin?
- Syrian Arab Republic ranks 71st out of 155 countries with data for 2021.
- Where does this Syrian Arab Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).